Diagnostic value of BNP in diastolic heart failure

Diagnostic Value of NT-pro BNP Biomarker and Echocardiography in Cardiac Involvements in Beta-thalassemia Patients

Background N-terminal pro–B-type natriuretic peptide (NT-proBNP) is a marker to evaluate the cardiac involvement in thalassemia. We aimed to evaluate conventional and tissue Doppler echocardiography findings and its relation to plasma NT-pro BNP, Ferritin and Iron levels in beta-thalassemia patients. Materials and Methods This study performed on 164 participants equal of major beta- thalassemi...

New diagnostic and therapeutic possibilities for diastolic heart failure.

Despite the fact that up to half of all heart failure occurs in patients without evidence of systolic cardiac dysfunction, there are no universally accepted diagnostic markers and no approved therapies for heart failure with preserved ejection fraction (HFpEF). HFpEF, otherwise known as diastolic heart failure, has nearly the same grim prognosis as systolic heart failure, and diastolic heart fa...

Defining diastolic heart failure: a call for standardized diagnostic criteria.

Congestive heart failure (CHF) is a major public health problem in developed countries.1–3 It is a significant burden to patients, healthcare providers, and society.2–4 Several hospital-based reports have documented that a high proportion of patients with CHF have normal left ventricular (LV) systolic function,5 and 4 different epidemiological investigations further confirmed that nearly half o...

Diastolic Heart Failure

Diastolic heart failure.

to the editor: Zile et al. (May 6 issue) 1 conclude that heart failure develops in patients with a normal ejection fraction because of abnormal active and passive diastolic function. However, the applicability of this conclusion to all such patients is uncertain for several reasons. First, accurate assessment of left ventricular volume, on which the conclusions critically depend, requires a thr...